Medigen Biotechnology Corporation

This study tests whether adding donor natural killer (NK) cells to standard chemotherapy can help prevent cancer from coming back after surgery for pancreatic or bile duct cancer. About 42 adults who had their tumor removed will receive either chemotherapy alone or chemotherapy p…

This early-stage trial tests a new treatment called Magicell-NK for people with stage I or IIa colon cancer who have already had surgery to remove the tumor. The treatment uses a patient's own natural killer (NK) cells, which are grown and activated in a lab and then infused back…